Skip to main content
Innovations Inspired by
life
Search
Menu
Search
Hamburger
Our Company
Who we are
History
Culture
Board of Directors
Leadership Team
OUR RESEARCH
Therapeutic focus
Delivery Technologies
Research Programs
R&D Pipeline
Our Medicines
Xelpros™
Elepsia™ XR
Business Development
Strategy
Partner with us
Investors
Financials
Annual reports
Presentations
Chairman's Speech
Committees of Board of Directors
Shareholding pattern
Announcements & Disclosures
Policies & Codes
Listing Information
FAQ’s
Investors Contact
Go green
Media
Press Releases
Presentations
Careers
Overview
Apply Now
Contact Us
Investors
»
Announcements & Disclosures
Investors
Financials
Annual reports
Presentations
Chairman's Speech
Committees of BOD's
Shareholding pattern
Announcements & Disclosures
Policies & Codes
Listing Information
FAQ’s
Investors Contact
Go green
Announcements & Disclosures
Return of Product Rights by partner for ELEPSIA™ XR 1000/1500 mg
Download
Receipt of Demand Order from from the Office of the Commissioner of GST & Central Excise
Download
Shareholding Pattern - 11th January 2019 POST
Download
Notice of Board Meeting on 4th February 2019
Download
Mandatory Dematerialization for Transfer of Securities
Download
Achievement of milestone – Commercialisation of XELPROS™
Download
Allotment of 6060606 equity shares on conversion of warrants
Download
Receipt of US FDA Approval of ELEPSIA(tm) XR 1000mg and ELEPSIA(tm) XR 1500mg
Download
Inter-se change in the shareholding of certain promoter group entities on account of Scheme of Amalgamation
Download
Notice of Board Meeting on 29th October 2018
Download
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
Next ›
Last page
Last »
